Cephalosporin-resistant gonorrhea in North America

doi:10.1001/jama.2012.205107

Editorial

. 2013 Jan 9;309(2):185-7.

doi: 10.1001/jama.2012.205107.

Cephalosporin-resistant gonorrhea in North America

Robert D Kirkcaldy, Gail A Bolan, Judith N Wasserheit

PMID: 23299612
PMCID: PMC6749818
DOI: 10.1001/jama.2012.205107

Editorial

Cephalosporin-resistant gonorrhea in North America

Robert D Kirkcaldy et al. JAMA. 2013.

. 2013 Jan 9;309(2):185-7.

doi: 10.1001/jama.2012.205107.

Authors

Robert D Kirkcaldy, Gail A Bolan, Judith N Wasserheit

PMID: 23299612
PMCID: PMC6749818
DOI: 10.1001/jama.2012.205107

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Comment in

Cephalosporin resistance in Neisseria gonorrhoeae infections.
Klausner JD, Kerndt P. Klausner JD, et al. JAMA. 2013 May 15;309(19):1989. doi: 10.1001/jama.2013.4078. JAMA. 2013. PMID: 23677303 No abstract available.
Cephalosporin resistance in Neisseria gonorrhoeae infections--reply.
Kirkcaldy RD, Bolan GA, Wasserheit JN. Kirkcaldy RD, et al. JAMA. 2013 May 15;309(19):1990-1. doi: 10.1001/jama.2013.4084. JAMA. 2013. PMID: 23677305 Free PMC article. No abstract available.

Comment on

Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.
Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, Siebert H, Towns L, Melano RG, Low DE. Allen VG, et al. JAMA. 2013 Jan 9;309(2):163-70. doi: 10.1001/jama.2012.176575. JAMA. 2013. PMID: 23299608

Cited by

Priorities for sexually transmitted infection vaccine research and development: Results from a survey of global leaders and representatives.
Plotnikoff KM, Donken R, Smith L, Cameron C, LaMontagne DS, Bettinger JA, Sadarangani M, Grennan T, Racey CS, Hybiske K, Naus M, Monteiro A, Ogilvie GS. Plotnikoff KM, et al. Vaccine X. 2021 Jun 29;8:100107. doi: 10.1016/j.jvacx.2021.100107. eCollection 2021 Aug. Vaccine X. 2021. PMID: 34401741 Free PMC article.
Availability of Injectable Antimicrobial Drugs for Gonorrhea and Syphilis, United States, 2016.
Pearson WS, Cherry DK, Leichliter JS, Bachmann LH, Cummings NA, Hogben M. Pearson WS, et al. Emerg Infect Dis. 2019 Nov;25(11):2154-2156. doi: 10.3201/eid2511.190764. Emerg Infect Dis. 2019. PMID: 31625857 Free PMC article.
Aminomethyl Spectinomycins as Therapeutics for Drug-Resistant Gonorrhea and Chlamydia Coinfections.
Butler MM, Waidyarachchi SL, Connolly KL, Jerse AE, Chai W, Lee RE, Kohlhoff SA, Shinabarger DL, Bowlin TL. Butler MM, et al. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e00325-18. doi: 10.1128/AAC.00325-18. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29483122 Free PMC article.
Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?
Cheesman MJ, Ilanko A, Blonk B, Cock IE. Cheesman MJ, et al. Pharmacogn Rev. 2017 Jul-Dec;11(22):57-72. doi: 10.4103/phrev.phrev_21_17. Pharmacogn Rev. 2017. PMID: 28989242 Free PMC article. Review.
Future prospects for new vaccines against sexually transmitted infections.
Gottlieb SL, Johnston C. Gottlieb SL, et al. Curr Opin Infect Dis. 2017 Feb;30(1):77-86. doi: 10.1097/QCO.0000000000000343. Curr Opin Infect Dis. 2017. PMID: 27922851 Free PMC article. Review.

See all "Cited by" articles

References

1. Global incidence and prevalence of selected curable sexually transmitted infections: 2008 World Health Organization. http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimat.... Accessed December 17, 2012.
1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2011. Atlanta, GA: US Dept of Health & Human Services; 2012.
1. Weinstock HS, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6–10. - PubMed
1. Braunstein SL, Ingabire CM, Kestelyn E, et al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis. 2011; 38(5):385–394. - PubMed
1. Centers for Disease Control and Prevention (CDC). Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332–336. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

CC999999/Intramural CDC HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Global incidence and prevalence of selected curable sexually transmitted infections: 2008 World Health Organization. http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimat.... Accessed December 17, 2012.

[2] Global incidence and prevalence of selected curable sexually transmitted infections: 2008 World Health Organization. http://www.who.int/reproductivehealth/publications/rtis/2008_STI_estimat.... Accessed December 17, 2012.

[3] Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2011. Atlanta, GA: US Dept of Health & Human Services; 2012.

[4] Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2011. Atlanta, GA: US Dept of Health & Human Services; 2012.

[5] Weinstock HS, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6–10. - PubMed

[6] Weinstock HS, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6–10. - PubMed

[7] Braunstein SL, Ingabire CM, Kestelyn E, et al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis. 2011; 38(5):385–394. - PubMed

[8] Braunstein SL, Ingabire CM, Kestelyn E, et al. High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis. 2011; 38(5):385–394. - PubMed

[9] Centers for Disease Control and Prevention (CDC). Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332–336. - PubMed

[10] Centers for Disease Control and Prevention (CDC). Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332–336. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cephalosporin-resistant gonorrhea in North America

Cephalosporin-resistant gonorrhea in North America

Authors

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical